an older formulation of the Danish pharma's blockbuster insulin analogue product insulin aspart. Sanofi-Aventis' Merilog version of the product has been cleared for the treatment of adult and ...

Non-profit drugmaker Civica Rx has said it will launch biosimilars of three big-selling insulin products in the US by 2024 to help diabetic patients struggling with the cost of the drugs.

and insulin aspart (a rapid-acting insulin). If the funding proposal is approved, Pharmac’s Senior Therapeutic Group Manager, Logan Heyes says the medicine could benefit 13,000 people with ...

28 days Prescribing information 70% insulin aspart protamine suspension and 30% insulin as part injection (rDNA origin) pen fill cartridge Novolog Mix 70/30 pen fill cartridge (Novo Nordisk ...

President and CEO Ned McCoy shared with Becker's some of the company's key objectives for the year, including the launch of some of the first medications from its Petersburg, Va.-based plant, the ...

Due to phenomenal presale ticket demand for Alex Warren’s Cheaper Than Therapy Global Tour, Frontier Touring is thrilled to ...

As of March 11, 2025, three stocks in the health care sector could be flashing a real warning to investors who value momentum ...

Mallinckrodt and Endo plan to combine their generic pharmaceuticals businesses and Endo's sterile injectables business after ...

Empagliflozin is a SGLT-2 inhibitor and it has shown to significantly reduce the progression of kidney disease and heart failure.